Helene Eltchaninoff

Sep 1, 2024 | radcliffecardiology.com | Harriette Van Spall |Mirvat Alasnag |Vijay Kunadian |Helene Eltchaninoff

ESC Congress 2024 — No difference in cardiovascular outcomes between invasive and conservative strategies in elderly NSTEMI patients. Principal Investigator, Prof Vijay Kunadian (Newcastle upon Tyne Hospitals NHS Trust, UK) join us in London to discuss the key findings from the SENIOR RITA trial (NCT03052036; Newcastle-upon-Tyne Hospitals NHS Trust). The SENIOR-RITA trial is a multicenter, open-label study enrolling 1518 patients aged 75 years or older who experienced a type 1 NSTEMI.

Sep 1, 2024 | radcliffecardiology.com | Harriette Van Spall |David Ferreira |Jacob Lønborg |Helene Eltchaninoff

ESC Congress 24 — Fasting prior to cardiac catheterisation surgery significantly improves patient satisfaction score. We are joined onsite by Dr David Ferreira (John Hunter Hospital, AU) to discuss the findings from the SCOFF Trial (ACTRN12622001455752), which randomized 716 patients in a 1:1 fashion to either a no fasting group, or a fasting group. The fasting group were allowed solid foods 6 hours prior to surgery, and clear liquids up to 2 hours before surgery.

Aug 31, 2024 | radcliffecardiology.com | Harriette Van Spall |Mirvat Alasnag |Helene Eltchaninoff |Volker Rudolph

ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year. Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).

Aug 31, 2024 | radcliffecardiology.com | Harriette Van Spall |Mirvat Alasnag |Helene Eltchaninoff |Julia Grapsa

Video Published: Views: 11 Likes: 0 Average (ratings) ESC Congress 2024 — Transcatheter aortic valve replacement shows superiority over surgical aortic valve replacement for women with severe aortic stenosis. Host, Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Helene Eltchaninoff (University Hospital of Rouen, FR) to discuss key findings from the RHEIA trial (NCT04160130; Optimapharm).

May 10, 2024 | eurointervention.pcronline.com | Helene Eltchaninoff

Alain Cribier was an interventional cardiologist who played a key role in innovations that changed the way medicine is practised today, revolutionising the management of heart valve disease forever. He will always be remembered for his discoveries, and he belongs to that exclusive group of doctors and scientists who have pioneered life-changing techniques − which are the foundation of the modern treatment of heart valve disease.